Market Risers: Anglo Pacific Group, Ashtead Group, AstraZeneca, BAE Systems

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Stock in Anglo Pacific Group ticker lookup code: LON:APF has stepped up 6.28% or 11.5 points throughout the session so far. Traders have so far held a positive outlook during this period. The period high was 194.5 and hitting a low of 181. The volume total for shares traded up to this point was 136,045 with the daily average at 150,240. The 52 week high for the shares is 229 which comes in at 46 points difference from the previous days close and the 52 week low at 134.88 making a difference of 48.12 points. Anglo Pacific Group now has a 20 moving average of 185.94 and a 50 day simple moving average now at 195.29. Market capitalisation for the company is £352.96m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Anglo Pacific Group being recorded at Wednesday, December 11, 2019 at 12:44:09 PM GMT with the stock price trading at 194.5 GBX.

Shares of Ashtead Group ticker code: LON:AHT has gained 1.76% or 39 points during the course of today’s session so far. Buyers have so far held a positive outlook while the stock has been in play. The periods high has already touched 2278 dipping to 2217. Volume total for shares traded at this point reached 817,988 whilst the average number of shares exchanged is 1,552,965. The 52 week high price for the shares is 2468 amounting to 248 points in difference on the previous days close and a 52 week low being 1572.5 is a variance of 647.5 points. Ashtead Group now has a 20 moving average of 2380.94 and a 50 day MA at 2306.92. The market capitalisation is now £10,266.11m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Ashtead Group being recorded at Wednesday, December 11, 2019 at 12:45:11 PM GMT with the stock price trading at 2259 GBX.

Shares in AstraZeneca EPIC code: LON:AZN has stepped up 1.15% or 83 points during the course of today’s session so far. Investors have remained positive during the session. Range high for the period so far is 7338 while the low for the session was 7277. The number of shares traded by this point in time totalled 345,409 with the daily average number around 1,998,360. The 52 week high price for the shares is 7646 about 400 points different to the previous business close and a 52 week low sitting at 5312 a difference of some 1934 points. AstraZeneca now has a 20 simple moving average of 7440.84 and a 50 day simple moving average now at 7324.4. The market cap now stands at £96,189.48m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca being recorded at Wednesday, December 11, 2019 at 12:45:13 PM GMT with the stock price trading at 7329 GBX.

Stock in BAE Systems with ticker code: LON:BA has gained 1.05% or 5.8 points throughout today’s trading session so far. Traders have so far held a positive outlook during the session. Range high for the period has seen 557.8 dropping as low as 551.2. The amount of shares exchanged has so far reached 1,158,761 with the daily average at 6,359,827. The stock 52 week high is 590.8 around 39.4 points in difference on the previous days close and a 52 week low being 439.4 is a variance of 112 points. BAE Systems now has a 20 SMA of 572.83 with a 50 day moving average now of 567.12. This puts the market capitalisation now at £17,859.57m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for BAE Systems being recorded at Wednesday, December 11, 2019 at 12:45:05 PM GMT with the stock price trading at 557.2 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
    AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.

      Search

      Search